Prudential Financial’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-64,286
| Closed | -$43.3K | – | 2417 |
|
|
2025
Q3 | $43.3K | Buy |
+64,286
| New | +$34.7K | ﹤0.01% | 2351 |
|
|
2025
Q1 | – | Sell |
-11,343
| Closed | -$11.6K | – | 2368 |
|
|
2024
Q4 | $11.6K | Buy |
+11,343
| New | +$20.7K | ﹤0.01% | 2279 |
|
|
2024
Q2 | – | Sell |
-94,236
| Closed | -$63.2K | – | 2774 |
|
|
2024
Q1 | $63.2K | Buy |
94,236
+3,700
| +4% | +$2.68K | ﹤0.01% | 2577 |
|
|
2023
Q4 | $49.2K | Sell |
90,536
-180,000
| -67% | -$83K | ﹤0.01% | 2550 |
|
|
2023
Q3 | $162K | Sell |
270,536
-116,400
| -30% | -$125K | ﹤0.01% | 2417 |
|
|
2023
Q2 | $503K | Buy |
386,936
+223,450
| +137% | +$305K | ﹤0.01% | 2109 |
|
|
2023
Q1 | $288K | Buy |
+163,486
| New | +$467K | ﹤0.01% | 2275 |
|
|
2021
Q4 | – | Sell |
-14,460
| Closed | -$130K | – | 2692 |
|
|
2021
Q3 | $130K | Buy |
14,460
+3,319
| +30% | +$32.8K | ﹤0.01% | 2511 |
|
|
2021
Q2 | $133K | Buy |
+11,141
| New | +$126K | ﹤0.01% | 2482 |
|
|
2021
Q1 | – | Sell |
-10,541
| Closed | -$165K | – | 2531 |
|
|
2020
Q4 | $165K | Sell |
10,541
-655
| -6% | -$7.67K | ﹤0.01% | 2371 |
|
|
2020
Q3 | $106K | Sell |
11,196
-341
| -3% | -$3.69K | ﹤0.01% | 2363 |
|
|
2020
Q2 | $103K | Buy |
11,537
+310
| +3% | +$2.88K | ﹤0.01% | 2334 |
|
|
2020
Q1 | $72K | Sell |
11,227
-946
| -8% | -$7.02K | ﹤0.01% | 2288 |
|
|
2019
Q4 | $102K | Buy |
12,173
+202
| +2% | +$1.86K | ﹤0.01% | 2376 |
|
|
2019
Q3 | $108K | Sell |
11,971
-1,907
| -14% | -$21.4K | ﹤0.01% | 2359 |
|
|
2019
Q2 | $149K | Buy |
13,878
+1,270
| +10% | +$13.5K | ﹤0.01% | 2373 |
|
|
2019
Q1 | $120K | Buy |
12,608
+1,982
| +19% | +$20.2K | ﹤0.01% | 2365 |
|
|
2018
Q4 | $122K | Sell |
10,626
-120
| -1% | -$1.49K | ﹤0.01% | 2290 |
|
|
2018
Q3 | $182K | Buy |
10,746
+100
| +0.9% | +$1.52K | ﹤0.01% | 2340 |
|
|
2018
Q2 | $151K | Sell |
10,646
-494,890
| -98% | -$8.22M | ﹤0.01% | 2372 |
|
|
2018
Q1 | $9.61M | Buy |
505,536
+388,480
| +332% | +$8.31M | 0.01% | 921 |
|
|
2017
Q4 | $1.92M | Buy |
+117,056
| New | +$1.74M | ﹤0.01% | 1606 |
|
|
2016
Q2 | – | Sell |
-228,816
| Closed | -$1.38M | – | 2327 |
|
|
2016
Q1 | $1.38M | Buy |
+228,816
| New | +$1.37M | ﹤0.01% | 1705 |
|
|
2014
Q3 | – | Sell |
-15,420
| Closed | -$235K | – | 2295 |
|
|
2014
Q2 | $235K | Buy |
+15,420
| New | +$222K | ﹤0.01% | 2244 |
|
Other funds holding SGMO
WA
Prudential Financial's SGMO Position: Q4 2025 in Review
Prudential Financial sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2025, closing a stake of 64,286 shares — an estimated $43.3K sold.
Prudential Financial first reported a position in SGMO in Q2 2014 and held it in 24 quarters. The position peaked at $9.61M in Q1 2018. 105 funds tracked by Wall St. Rank hold SGMO as of Q4 2025.
- Prudential Financial reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2025 after selling out during the quarter.
- Prudential Financial sold 64,286 SANGAMO THERAPEUTICS INC shares in Q4 2025, an estimated $43.3K.
- Prudential Financial first reported a position in SANGAMO THERAPEUTICS INC in Q2 2014 and held it in 24 quarters.
- Prudential Financial's SANGAMO THERAPEUTICS INC position peaked at $9.61M in Q1 2018.
- 105 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2025.
Based on Prudential Financial's 13F filing for Q4 2025, filed 13 Feb 2026.